Real-world, 52-week Prospective Study to Capture the Reasons for Switch to Triple Combination Therapy, Assess the Clinical and Patient Reported Outcomes in Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Treated With Trixeo Aerosphere™ in Routine Care Settings in Greece
Clinical trial NCT05915182 · COMPLETED
Trial details
- NCT number
- NCT05915182
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-21
- Primary completion
- 2025-03-28
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.